Phio Pharmaceuticals(PHIO) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update Recent Corporate Updates Financial Results Cash Position At March 31, 2024, we had cash of $6.5 million as compared with$8.5 million at December 31, 2023. Research and Development Expenses Research and development expenses were $1.1 million for the three months ended March 31, 2024 as compared with$2.1 million for the three months ended March 31, 2023, a decrease of 46%. The decrease was primarily driven by the Company' ...